Luminary Lecture Series - Anna Dumitriu Sculture/installation/digital media artist
Meeting ID: 844 2489 1727 Passcode: 443340
Anna Dumitriu will discuss the concepts and processes behind her artworks which explore infectious diseases, synthetic biology and genomics. Equally at home in the laboratory as the art studio, Dumitriu will discuss key past works including her “Plague Dress”, embedded with real plague DNA and artworks involving CRISPR genetic modification and antibiotic resistance. Furthermore, she will give an insight into new artworks created under the shadow of the COVID-19 pandemic. Her work is frequently inspired by the history behind research, situating contemporary issues within cultural contexts, weaving narratives and telling stories and drawing threads across time. She is currently developing new works around the “Collateral Effects” of the COVID-19 pandemic and around gene editing technologies.
Anna Dumitriu is an award winning internationally renowned British artist who works with BioArt, sculpture, installation, and digital media to explore our relationship to infectious diseases, synthetic biology and robotics. Past exhibitions include ZKM, Ars Electronica, BOZAR, The Picasso Museum, HeK Basel, Science Gallery Detroit, MOCA Taipei, LABoral, Art Laboratory Berlin, and Eden Project. She holds visiting research fellowships at the University of Hertfordshire, Brighton and Sussex Medical School, and Waag Society, as well as artist-in-residence roles with the Modernising Medical Microbiology Project at the University of Oxford, and with the National Collection of Type Cultures at Public Health England. She was the 2018 President of the Science and the Arts Section of the British Science Association. Her work has featured in many significant publications including Frieze, Artforum International Magazine, Leonardo Journal, The Art Newspaper, Nature and The Lancet. Current collaborations include the Institute of Microbiology and Microbial Biotechnology at BOKU – Universität für Bodenkultur in Vienna, the EU H2020 CHIC Consortium, the University of Leeds and the Institute of Epigenetics and Stem Cells at HelmholtzZentrum in München.